Corticotroph tumor progression during long-term therapy with osilodrostat  in a patient with persistent Cushing’s disease

ConclusionThis case highlights the importance of monitoring ACTH and corticotroph tumor size in patients with persistent CD, either under effective treatment with steroidogenesis inhibitors or after bilateral adrenalectomy.

Source: Pituitary - October 19, 2020 Category: Endocrinology Source Type: research